Etienne Brain, Medical Oncologist at Institut Curie/Saint-Cloud, shared a post on LinkedIn:
“Key SABCS presentation by Luca Malorni.
The Touch trial or when chemotherapy-free optimized endocrine + anti-HER2 Treatment challenges chemotherapy-based standard neoadjuvant strategy.
Promising results for older women with breast cancer.”
More posts featuring Etienne Brain.